A high-throughput microfluidic dental plaque biofilm system to visualize and quantify the effect of antimicrobials

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 11, 2013, Pages 2550-2560

  Nance, William ^a   Dowd, Scot ^b   Samarian, D ^a   Chludzinski, J ^a   Delli, J ^c   Battista, J ^d   Rickard, Alexander ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Molecular Research LP MR DNA   (United States)

^c W Nuhsbaum Inc   (United States)

^d Fluxion Biosciences   (United States)

Author keywords

Confocal scanning laser microscopy; Live Dead staining; Microfluidics; Multi species biofilm; Pyrosequencing

Indexed keywords

ANTIINFECTIVE AGENT; CETYLPYRIDINIUM SALT; MOUTHWASH;

AGGREGATIBACTER; AMPLICON; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOFILM; CONTROLLED STUDY; FUSOBACTERIUM; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN EXPERIMENT; IMAGING SOFTWARE; MICROFLUIDIC ANALYSIS; MOUTH HYGIENE; NEISSERIA; NORMAL HUMAN; PORPHYROMONAS; PYROSEQUENCING; SCANNING ELECTRON MICROSCOPE; STREPTOCOCCUS; THREE DIMENSIONAL IMAGING; TOOTH PLAQUE; VEILLONELLA;

CONFOCAL SCANNING LASER MICROSCOPY; LIVE/DEAD STAINING; MICROFLUIDICS; MULTI-SPECIES BIOFILM; PYROSEQUENCING;

ADULT; ANTI-INFECTIVE AGENTS; BIOFILMS; CETYLPYRIDINIUM; DENTAL PLAQUE; HUMANS; MICROBIAL CONSORTIA; MICROFLUIDICS; MICROSCOPY, CONFOCAL; SALIVA;

EID: 84886235652     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt211     Document Type: Article

References (85)

1. Costerton JW, Cheng KJ, Geesey GG et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol 1987; 41: 435-64.
2. Stoodley P, Sauer K, Davies DG et al. Biofilms as complex differentiated communities. Annu Rev Microbiol 2002; 56: 187-209.
3. Armitage GC. Basic features of biofilms-why are they difficult therapeutic targets?. Ann R Australas Coll Dent Surg 2004; 17: 30-4.
4. Gilbert P, Maira-Litran T, McBain AJ et al. The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol 2002; 46: 202-56.
5. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9: 34-9.
6. Roberts A.P, Mullany P. Oral biofilms: a reservoir of transferable, bacterial, antimicrobial resistance. Expert Rev Anti Infect Ther 2010; 8: 1441-50.
7. Stewart PS, Rayner J, Roe F et al. Biofilm penetration and disinfection efficacy of alkaline hypochlorite and chlorosulfamates. J Appl Microbiol 2001; 91: 525-32.
8. Stewart PS. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob Agents Chemother 1996; 40: 2517-22.
9. Peters BM, Jabra-Rizk MA, O'May GA et al. Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev 2012; 25: 193-213.
10. Leriche V, Briandet R, Carpentier B. Ecology of mixed biofilms subjected daily to a chlorinated alkaline solution: spatial distribution of bacterial species suggests a protective effect of one species to another. Environ Microbiol 2003; 5: 64-71.
11. Umland TC, Schultz LW, MacDonald U et al. In vivo-validated essential genes identified in Acinetobacter baumannii by using human ascites overlap poorly with essential genes detected on laboratory media. MBio 2012; 3: pii: e00113-12.
12. Foster JS, KolenbranderPE.Developmentofamultispecies oralbacterial community in a saliva-conditioned flow cell. Appl Environ Microbiol 2004; 70: 4340-8.
13. Whittaker CJ, Klier CM, Kolenbrander PE. Mechanisms of adhesion by oral bacteria. Annu Rev Microbiol 1996; 50: 513-52.
14. Kolenbrander PE, Andersen RN, Blehert DS et al. Communicationamong oral bacteria. Microbiol Mol Biol Rev 2002; 66: 486-505.
15. Kolenbrander PE, Palmer RJ Jr, Rickard AH et al. Bacterial interactions and successions during plaque development. Periodontol 2000 2006; 42: 47-79.
16. Aas JA, Paster BJ, Stokes LN et al. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005; 43: 5721-32.
17. Marsh PD. Dental plaque as a biofilm and a microbial community - implications for health and disease. BMC Oral Health 2006; 6 Suppl 1: S14.
18. Bernimoulin JP. Recent concepts in plaque formation. J Clin Periodontol 2003; 30 Suppl 5: 7-9.
19. White DJ. Dental calculus: recent insights into occurrence, formation, prevention, removal and oral health effects of supragingival and subgingival deposits. Eur J Oral Sci 1997; 105: 508-22.
20. Whitmore SE, Lamont RJ. The pathogenic persona of community-associated oral streptococci. Mol Microbiol 2011; 81: 305-14.
21. Lamont RJ, Jenkinson HF. Subgingival colonization by Porphyromonas gingivalis. Oral Microbiol Immunol 2000; 15: 341-9.
22. Marsh PD. Controlling the oral biofilm with antimicrobials. J Dent 2010; 38 Suppl 1: S11-5.
23. Davies RM. Toothpaste in the control of plaque/gingivitis and periodontitis. Periodontol 2000 2008; 48: 23-30.
24. TelesRP, Teles FR. Antimicrobial agentsusedin the control of periodontal biofilms: effective adjuncts to mechanical plaque control? Braz Oral Res 2009; 23 Suppl 1: 39-48.
25. Pan PC, Harper S, Ricci-Nittel D et al. In-vitro evidence for efficacy of antimicrobial mouthrinses. J Dent 2010; 38 Suppl 1: S16-20.
26. Foster JS, Pan PC, Kolenbrander PE. Effects of antimicrobial agents on oral biofilms in a saliva-conditioned flowcell. Biofilms 2004; 1: 5-12.
27. Shapiro S, Giertsen E, Guggenheim B. An in vitro oral biofilm model for comparing the efficacy of antimicrobial mouthrinses. Caries Res 2002; 36: 93-100.
28. Wilson M. Susceptibility of oral bacterial biofilms to antimicrobial agents. J Med Microbiol 1996; 44: 79-87.
29. Wilson M, Patel H, Fletcher J. Susceptibility of biofilms of Streptococcus sanguis to chlorhexidine gluconate and cetylpyridinium chloride. Oral Microbiol Immunol 1996; 11: 188-92.
30. McBain AJ. Chapter 4: In vitro biofilm models: an overview. Adv Appl Microbiol 2009; 69: 99-132.
31. Bercy P, Lasserre J. Susceptibility to various oral antiseptics of Porphyromonas gingivalis W83 within a biofilm. Adv Ther 2007; 24: 1181-91.
32. Wilson M, Patel H, Noar JH. Effect of chlorhexidine on multi-species biofilms. Curr Microbiol 1998; 36: 13-8.
33. Cuadra-Saenz G, Rao DL, Underwood AJ et al. Autoinducer-2 influences interactions amongst pioneer colonizing streptococci in oral biofilms. Microbiology 2012; 158: 1783-95.
34. Benoit MR, Conant CG, Ionescu-Zanetti C et al. New device for high-throughput viability screening of flow biofilms. Appl Environ Microbiol 2010; 76: 4136-42.
35. Wong L, Sissons C. A comparison of human dental plaque microcosm biofilms grown in an undefined medium and a chemically defined artificial saliva. Arch Oral Biol 2001; 46: 477-86.
36. Sissons CH. Artificial dental plaque biofilm model systems. Adv Dent Res 1997; 11: 110-26.
37. Pratten J, Wills K, Barnett P et al. In vitro studies of the effect of antiseptic-containing mouthwashes on the formation and viability of Streptococcus sanguis biofilms. J Appl Microbiol 1998; 84: 1149-55.
38. Bjorklund M, Ouwehand AC, Forssten SD. Improved artificial saliva for studying the cariogenic effect of carbohydrates. Curr Microbiol 2011; 63: 46-9.
39. Ledder RG, Gilbert P, Pluen A et al. Individual microflora beget unique oral microcosms. J Appl Microbiol 2006; 100: 1123-31.
40. McBainAJ, Sissons C, LedderRGet al.Developmentandcharacterization of a simple perfused oral microcosm. J Appl Microbiol 2005; 98: 624-34.
41. Pratten J, Wilson M. Antimicrobial susceptibility and composition of microcosm dental plaques supplemented with sucrose. Antimicrob Agents Chemother 1999; 43: 1595-9.
42. AmerongenAV, Veerman EC. Saliva-the defender of the oral cavity. Oral Dis 2002; 8: 12-22.
43. Orstavik D. Bacterial adherence related to agglutination and surface film formation. Adv Exp Med Biol 1978; 107: 869-75.
44. Yamanaka W, Takeshita T, Shibata Y et al. Compositional stability of a salivary bacterial population against supragingival microbiota shift following periodontal therapy. PLoS One 2012; 7: e42806.
45. Rao D, Arvanitidou E, Du-Thumm L et al. Efficacy of an alcohol-free CPC-containing mouthwash against oral multispecies biofilms. J Clin Dent 2011; 22: 187-94.
46. De Jong MH, Van der Hoeven JS, Van Os JH. Growth of micro-organisms fromsupragingival dental plaque on saliva agar. J Dent Res 1986; 65: 85-8.
47. Heydorn A, Nielsen AT, Hentzer M et al. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 2000; 146: 2395-407.
48. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9: 671-5.
49. Vornhagen J, Stevens M, McCormick DW et al. Coaggregation occurs amongst bacteria within and between biofilms in domestic showerheads. Biofouling 2013; 29: 53-68.
50. Ishak HD, Plowes R, Sen R et al. Bacterial diversity in Solenopsis invicta and Solenopsis geminata ant colonies characterized by 16S amplicon 454 pyrosequencing. Microb Ecol 2011; 61: 821-31.
51. Capone KA, Dowd SE, Stamatas GN et al. Diversity of the human skin microbiome early in life. J Invest Dermatol 2011; 131: 2026-32.
52. Bailey MT, Dowd SE, Parry NM et al. Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. Infect Immun 2010; 78: 1509-19.
53. Handl S, Dowd SE, Garcia-Mazcorro JF et al. Massive parallel 16S rRNA gene pyrosequencing reveals highly diverse fecal bacterial and fungal communities in healthy dogs and cats. FEMS Microbiol Ecol 2011; 76: 301-10.
54. Callaway TR, Dowd SE, Edrington TS et al. Evaluation of bacterial diversity in the rumen and feces of cattle fed different levels of dried distiller's grains plus solubles using bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP). J Anim Sci 2010; 88: 3977-83.
55. Pitta DW, Pinchak E, Dowd SE et al. Rumen bacterial diversity dynamics associated with changing from bermudagrass hay to grazed winter wheat diets. Microb Ecol 2010; 59: 511-22.
56. Caporaso JG, Kuczynski J, Stombaugh J et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010; 7: 335-6.
57. Chao A. Nonparametric estimation of the number of classes in a population. Scand J Stat 1984; 11: 265-70.
58. Rudney JD, Chen R, Lenton Pet al. Areproducible oral microcosm biofilm model for testing dental materials. J Appl Microbiol 2012; 113: 1540-53.
59. Busscher HJ, White DJ, Atema-Smit J et al. Surfactive and antibacterial activity of cetylpyridinium chloride formulations in vitro and in vivo. J Clin Periodontol 2008; 35: 547-54.
60. Corbin A, Pitts B, Parker A et al. Antimicrobial penetration and efficacy in an in-vitro oral biofilm model. Antimicrob Agents Chemother 2011; 55: 338-44.
61. Listgarten MA. The structure of dental plaque. Periodontol 2000 1994;5: 52-65.
62. Rickard AH, Gilbert P, High NJ et al. Bacterial coaggregation: an integral process in the development of multi-species biofilms. Trends Microbiol 2003; 11: 94-100.
63. Kolenbrander PE. Oral microbial communities: biofilms, interactions, and genetic systems. Annu Rev Microbiol 2000; 54: 413-37.
64. Short HB, Clark VL, Kellogg DS Jr et al. Anaerobic survival of clinical isolates and laboratory strains of Neisseria gonorrhoea: use in transfer and storage. J Clin Microbiol 1982; 15: 915-9.
65. Ritz HL. Fluorescent antibody staining of Neisseria, Streptococcus and Veillonella in frozen sections of human dental plaque. Arch Oral Biol 1969; 14: 1073-83.
66. Ritz HL. Microbial population shifts in developing human dental plaque. Arch Oral Biol 1967; 12: 1561-8.
67. Komoria R, Sato T, Takano-Yamamotoa Tet al. Microbial composition of dental plaque microflora on first molars with orthodontic bands and brackets, and the acidogenic potential of these bacteria. J Oral Biosci 2012; 54: 107-12.
68. Bik EM, Long CD, ArmitageGCet al. Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J 2010; 4: 962-74.
69. Gibbons RJ, Houte JV. Bacterial adherence in oral microbial ecology. Annu Rev Microbiol 1975; 29: 19-44.
70. Kolenbrander PE, London J. Adhere today, here tomorrow: oral bacterial adherence. J Bacteriol 1993; 175: 3247-52.
71. Van der Hoeven JS, Camp PJ. Synergistic degradation of mucin by Streptococcus oralis and Streptococcus sanguis in mixed chemostat cultures. J Dent Res 1991; 70: 1041-4.
72. van der Hoeven JS, van den Kieboom CW, Camp PJ. Utilization of mucin by oral Streptococcus species. Antonie Van Leeuwenhoek 1990; 57: 165-72.
73. Burne RA. Oral streptococci.products of their environment. J Dent Res 1998; 77: 445-52.
74. Burne RA, Quivey RG Jr, Marquis RE. Physiologic homeostasis and stress responses in oral biofilms. Methods Enzymol 1999; 310: 441-60.
75. Marquis RE. Oxygen metabolism, oxidative stress and acid-base physiology of dental plaque biofilms. J Ind Microbiol 1995; 15: 198-207.
76. Diaz PI, Chalmers NI, Rickard AH et al. Molecular characterization of subject-specific oral microflora during initial colonization of enamel. Appl Environ Microbiol 2006; 72: 2837-48.
77. Sharma PK, Gibcus MJ, van der Mei HC et al. Influence of fluid shear and microbubbles on bacterial detachment from a surface. Appl Environ Microbiol 2005; 71: 3668-73.
78. Lewis R, McKenzie D, Bagg J et al. Experience with a novel selective medium for isolation of Actinomyces spp. from medical and dental specimens. J Clin Microbiol 1995; 33: 1613-6.
79. Auschill TM, Arweiler NB, Netuschil L et al. Spatial distribution of vital and dead microorganisms in dental biofilms. Arch Oral Biol 2001; 46: 471-6.
80. Neu TR. Significance of bacterial surface-active compounds in interaction of bacteria with interfaces. Microbiol Rev 1996; 60: 151-66.
81. Smith RN, Andersen RN, Kolenbrander PE. Inhibition of intergeneric coaggregation among oral bacteria by cetylpyridinium chloride, chlorhexidine digluconate and octenidine dihydrochloride. J Periodontal Res 1991; 26: 422-8.
82. Marsh PD. Microbiological aspects of the chemical control of plaque and gingivitis. J Dent Res 1992; 71: 1431-8.
83. Gilbert P, Moore LE. Cationic antiseptics: diversity of action under a common epithet. J Appl Microbiol 2005; 99: 703-15.
84. Stewart PS, Grab L, Diemer JA. Analysis of biocide transport limitation in an artificial biofilm system. J Appl Microbiol 1998; 85: 495-500.
85. Hope CK, Wilson M. Analysis of the effects of chlorhexidine on oral biofilm vitality and structure based on viability profiling and an indicator of membrane integrity. Antimicrob Agents Chemother 2004; 48: 1461-8.